Loading …

 

 

BioFactura develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs

 

 

Location

Frederick, Maryland

Size

1 to 50 Employees

Benefits

View here.

Why BioFactura?

For over 15 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug and vaccine development and manufacturing technologies. The company grew from the founders’ recognition that there was a better way to run a company. By fostering a culture of curiosity, innovation, and love of science and engineering, the team has created a platform that can bring drugs to market faster with lower cost and superior quality. Boasting a number of notable successes and a team that’s rapidly expanding, they are becoming a clear employer-of-choice in the Capital Region.

"If you bring great solutions, you’ll advance and get more responsibility. We look for that spark, aptitude, and personality that will help people advance. When we talk to potential new team members, I want to know if they really love the thing they do. Is it something you can tell when you talk to them that it is part of them? Are they excited when they talk about what they do? Those are the kinds of professionals we want to join our team."

Darryl Sampey
President & Chief Executive Officer

"For scientists looking to explore how they can leave a bigger footprint and help people on a larger scale, BioFactura is the place to take your career. We are committed to developing high-value technologies that allow us to provide superior quality biosimilar medications that have unrivaled analytic comparability to branded drugs. Ultimately, these technologies will increase patient accessibility, bend the overall cost curve downward, and improve the quality of life for millions of patients. If you’re mission-driven, there’s not much more you can ask for."

Jeffrey Hausfeld, M.D., M.B.A.
Chairman of the Board & Chief Medical Officer

Featured Jobs

What BioFactura Does

BioFactura develops and manufactures high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals), biodefense medical countermeasures, and client-selected novel drugs using its patented StableFastTM Biomanufacturing Platform, the optimal choice for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 15 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug and vaccine development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.